Isolated Small Fiber Neuropathy Increasing in Incidence
Patients with small fiber neuropathy did not self-identify as disabled, but many have multiple comorbidities
ACS: Surgery May Follow Initial Antibiotic Therapy for Appendicitis
At one and two years, 40 and 46 percent of patients initially receiving antibiotics underwent subsequent appendectomy
Itepekimab Bests Placebo for Moderate-to-Severe Asthma
Incidence of events indicating loss of asthma control lower with itepekimab monotherapy in phase 2, proof-of-concept trial
Parkinson Disease Mortality Up in U.S. From 1999 to 2019
Increases seen across all age groups, both sexes, various racial/ethnic groups, different urban/rural classifications
Sotrovimab Cuts Risk for COVID-19 Progression in High-Risk Patients
Interim analysis shows lower risk for progression with sotrovimab versus placebo among high-risk patients with mild-to-moderate COVID-19
Fluvoxamine Cuts Hospitalizations in High-Risk COVID-19 Outpatients
Rate of high-risk COVID-19 outpatients needing prolonged emergency care or transfer to tertiary hospital lower with fluvoxamine versus placebo
Impact of Dietary Interventions Inconsistent in Rheumatoid Arthritis
Dietary interventions combined with omega-3 supplementation may provide additional benefit
Immunocompromised May Need Fourth COVID-19 Shot: CDC
Small studies have shown that fully vaccinated immunocompromised people account for ~44 percent of breakthrough cases leading to hospitalization
Merck Allows Poor Nations to Make COVID-19 Pill
Royalty-free license means companies in 105 countries can sublicense the formulation for antiviral pill molnupiravir and start making it












